MX9504422A - Tetrahidropirazolopiridinas biciclicas. - Google Patents
Tetrahidropirazolopiridinas biciclicas.Info
- Publication number
- MX9504422A MX9504422A MX9504422A MX9504422A MX9504422A MX 9504422 A MX9504422 A MX 9504422A MX 9504422 A MX9504422 A MX 9504422A MX 9504422 A MX9504422 A MX 9504422A MX 9504422 A MX9504422 A MX 9504422A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- tnf
- compounds
- production
- pyrazolopyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32643494A | 1994-10-20 | 1994-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9504422A true MX9504422A (es) | 1997-04-30 |
Family
ID=23272184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9504422A MX9504422A (es) | 1994-10-20 | 1995-10-19 | Tetrahidropirazolopiridinas biciclicas. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0787132A1 (fi) |
JP (1) | JPH09511758A (fi) |
KR (1) | KR970707124A (fi) |
CN (1) | CN1050129C (fi) |
AU (1) | AU702105B2 (fi) |
BR (1) | BR9504491A (fi) |
CZ (1) | CZ120097A3 (fi) |
FI (1) | FI954991A (fi) |
HU (1) | HUT77517A (fi) |
IL (1) | IL115667A0 (fi) |
MX (1) | MX9504422A (fi) |
NO (1) | NO971811L (fi) |
NZ (1) | NZ292991A (fi) |
PL (1) | PL319758A1 (fi) |
WO (1) | WO1996012720A1 (fi) |
ZA (1) | ZA958839B (fi) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP1147A (en) * | 1996-05-03 | 2003-02-25 | Pfizer | Substituted indazole derivatives and related compounds. |
EP0934307B1 (en) | 1996-06-19 | 2011-04-27 | Aventis Pharma Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
BR9712782A (pt) * | 1996-06-25 | 1999-12-07 | Pfizer | Derivados de indazol substituìdo e seu uso como inibidores de fosfodiesterose (pde) e fator de necrose de tumor (tnf) |
EP0983249B1 (en) * | 1997-05-08 | 2002-03-13 | Pfizer Products Inc. | Processes and intermediates for preparing substituted indazole derivatives |
IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
EA004515B1 (ru) | 1998-12-23 | 2004-04-29 | Дюпон Фармасьютикалз Компани | АЗОТСОДЕРЖАЩИЕ ГЕТЕРОБИЦИКЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa |
US6858616B2 (en) | 1998-12-23 | 2005-02-22 | Bristol-Myers Squibb Pharma Company | Nitrogen containing heterobicycles as factor Xa inhibitors |
US6326495B2 (en) | 1999-04-30 | 2001-12-04 | Pfizer Inc. | Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein |
PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
HU229824B1 (en) * | 2000-08-10 | 2014-08-28 | Pfizer Italia Srl | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
US6998408B2 (en) | 2001-03-23 | 2006-02-14 | Bristol-Myers Squibb Pharma Company | 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors |
EP1379245A4 (en) | 2001-04-18 | 2006-07-26 | Bristol Myers Squibb Co | 1, 4, 5, 6-TETRAHYDROPYRAZOLO- 3, 4-C-PYRIDINE-7-ONE AS FACTOR XA HEMMER |
CA2441772A1 (en) | 2001-04-18 | 2002-10-31 | Bristol-Myers Squibb Company | 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors |
US7902179B2 (en) | 2001-04-26 | 2011-03-08 | Ajinomoto Co., Inc. | Heterocyclic compounds |
PL204653B1 (pl) | 2001-09-21 | 2010-01-29 | Bristol Myers Squibb Co | Pochodna pirazolo [3, 4-c] pirydyny, jej zastosowanie i kompozycja farmaceutyczna |
TWI320039B (en) | 2001-09-21 | 2010-02-01 | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
CA2493625A1 (en) * | 2002-07-25 | 2004-02-19 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
AR045037A1 (es) * | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
FR2857363B1 (fr) * | 2003-07-10 | 2007-09-07 | Aventis Pharma Sa | 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation |
WO2007064914A2 (en) * | 2005-12-01 | 2007-06-07 | Elan Pharmaceuticals, Inc. | 5-(arylsulfonyl)-pyrazolopiperidines |
EP2276769A4 (en) | 2008-04-30 | 2011-08-17 | Almqvist Fredrik | NEW PEPTIDOMIMETIC COMPOUNDS |
EP2391627B1 (en) | 2009-01-28 | 2013-12-25 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
US7741350B1 (en) | 2009-01-28 | 2010-06-22 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
EP3152206A1 (en) * | 2014-06-06 | 2017-04-12 | Biogen MA Inc. | Atx modulating agents |
CN115043768A (zh) * | 2022-06-20 | 2022-09-13 | 新乡市润宇新材料科技有限公司 | 一种酸促进环丙基开环合成n-芳基吡咯烷-2-酮的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1463883A (fr) * | 1964-09-08 | 1966-07-22 | Ciba Geigy | Procédé de préparation de triaza-composés bicycliques |
US3340269A (en) * | 1964-09-08 | 1967-09-05 | Ciba Geigy Corp | 1-substituted 4-acyl-2, 3-dioxo-piperidine |
US3365459A (en) * | 1964-09-08 | 1968-01-23 | Ciba Geigy Corp | Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives |
EP0707585A1 (en) * | 1993-07-06 | 1996-04-24 | Pfizer Inc. | Bicyclic tetrahydro pyrazolopyridines |
-
1995
- 1995-10-06 NZ NZ292991A patent/NZ292991A/xx unknown
- 1995-10-06 EP EP95932148A patent/EP0787132A1/en not_active Withdrawn
- 1995-10-06 WO PCT/IB1995/000847 patent/WO1996012720A1/en not_active Application Discontinuation
- 1995-10-06 KR KR1019970702557A patent/KR970707124A/ko active IP Right Grant
- 1995-10-06 CZ CZ971200A patent/CZ120097A3/cs unknown
- 1995-10-06 PL PL95319758A patent/PL319758A1/xx unknown
- 1995-10-06 HU HU9702289A patent/HUT77517A/hu unknown
- 1995-10-06 CN CN95195743A patent/CN1050129C/zh not_active Expired - Fee Related
- 1995-10-06 AU AU35317/95A patent/AU702105B2/en not_active Ceased
- 1995-10-06 JP JP8513751A patent/JPH09511758A/ja active Pending
- 1995-10-18 IL IL11566795A patent/IL115667A0/xx unknown
- 1995-10-19 FI FI954991A patent/FI954991A/fi unknown
- 1995-10-19 MX MX9504422A patent/MX9504422A/es unknown
- 1995-10-19 ZA ZA958839A patent/ZA958839B/xx unknown
- 1995-10-20 BR BR9504491A patent/BR9504491A/pt not_active Application Discontinuation
-
1997
- 1997-04-18 NO NO971811A patent/NO971811L/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI954991A0 (fi) | 1995-10-19 |
ZA958839B (en) | 1997-04-21 |
CN1161040A (zh) | 1997-10-01 |
PL319758A1 (en) | 1997-08-18 |
CN1050129C (zh) | 2000-03-08 |
KR970707124A (ko) | 1997-12-01 |
WO1996012720A1 (en) | 1996-05-02 |
IL115667A0 (en) | 1996-01-19 |
NO971811L (no) | 1997-06-18 |
FI954991A (fi) | 1996-04-21 |
JPH09511758A (ja) | 1997-11-25 |
BR9504491A (pt) | 1997-05-20 |
AU702105B2 (en) | 1999-02-11 |
AU3531795A (en) | 1996-05-15 |
NO971811D0 (no) | 1997-04-18 |
HUT77517A (hu) | 1998-05-28 |
CZ120097A3 (cs) | 1998-01-14 |
NZ292991A (en) | 1999-02-25 |
EP0787132A1 (en) | 1997-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2166721A1 (en) | Bicyclic tetrahydro pyrazolopyridines | |
MX9504422A (es) | Tetrahidropirazolopiridinas biciclicas. | |
GR3035821T3 (en) | Substituted indoles as phosphodiesterase type iv inhibitors | |
DE60004655T2 (de) | Pyridin- und pyrimidinderivate und deren verwendung als inhibitor von cytokinbedingten krankheiten | |
DE69410121D1 (en) | Dihydro pyrazolopyrrole | |
CA2150812A1 (en) | Catechol diethers as selective pde iv inhibitors | |
WO2004024728A3 (en) | Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors | |
ATE370138T1 (de) | Neue imidazopyridine und ihre verwendung | |
MX9709897A (es) | 5-6-dihidro-9h-pirazol[3,4-c]-1,2,4-triazol[4,3-a]piridinas triciclicas y el uso de las mismas. | |
WO2007040438A3 (en) | Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders | |
GEP20033029B (en) | Substituted 1,8-Naphthyridin-4(1H)-Ones as Phosphodiesterase 4 Inhibitors | |
BG103725A (en) | Nicotineamide derivatives | |
TW200500364A (en) | Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors | |
MXPA02007981A (es) | Beta-carbolinas sustituidas con actividad que inhibe la ikb-cinasa. | |
CA2299399A1 (en) | Benzenesulfonamide inhibitors of pde-iv and their therapeutic use | |
JP2008521855A (ja) | 新規ピリドチエノピリミジン誘導体 | |
CA2223245A1 (en) | Catechol diethers derivatives useful as pharmaceutical agents | |
NO20021083L (no) | Pyrazolo[4,3-d]pyrimidiner | |
KR20060092297A (ko) | 유도성 일산화질소 합성효소 억제제인 이미다조피리딘유도체 | |
IL75012A (en) | 6-substituted-(1,3,4)-thiadiazolo(and thiazolo)(3,2-a)(1,2,3)triazolo(4,5-d)pyrimidine-9(1h)-ones | |
MY135776A (en) | PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | |
MXPA01009502A (en) | Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease | |
ZA200102187B (en) | Chemical compounds. |